Jupiter Neurosciences, Inc.
JUNS
$0.6251
-$0.0073-1.15%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 201.00K | 91.90K | 101.10K | 98.70K | 244.70K |
| Gross Profit | -201.00K | -91.90K | -101.10K | -98.70K | -244.70K |
| SG&A Expenses | 1.26M | 401.60K | 456.00K | 472.00K | 290.90K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.46M | 493.50K | 557.10K | 570.70K | 535.60K |
| Operating Income | -1.46M | -493.50K | -557.10K | -570.70K | -535.60K |
| Income Before Tax | -1.53M | -591.00K | 313.10K | -634.10K | -429.60K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.53M | -591.00K | 313.10K | -634.10K | -429.60K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.53M | -591.00K | 313.10K | -634.10K | -429.60K |
| EBIT | -1.46M | -493.50K | -557.10K | -570.70K | -535.60K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.05 | -0.02 | 0.01 | -0.02 | -0.02 |
| Normalized Basic EPS | -0.03 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.05 | -0.02 | 0.01 | -0.02 | -0.02 |
| Normalized Diluted EPS | -0.03 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 31.64M | 31.07M | 27.54M | 26.53M | 26.43M |
| Average Diluted Shares Outstanding | 31.64M | 31.07M | 30.59M | 26.53M | 26.43M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |